BDBM508685 2,2-difluoro-8-{[2-(trifluoromethyl)- 5,7-dihydro-6H-pyrrolo[3,4-d] pyrimidin-6-yl]methyl}[1,3]dioxolo [4,5-h][1,2,4]triazolo[1,5-c]quinazolin- 5-amine::US11046714, Example 121

SMILES Nc1nc2c3OC(F)(F)Oc3ccc2c2nc(CN3Cc4cnc(nc4C3)C(F)(F)F)nn12

InChI Key InChIKey=LLZYNYCNUWGZNC-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 508685   

TargetAdenosine receptor A2a(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM508685(2,2-difluoro-8-{[2-(trifluoromethyl)- 5,7-dihydro-...)
Affinity DataKi:  16nMAssay Description:The following table shows representative data for the compounds of the Examples as A2a receptor antagonists as determined by a competition binding as...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent